4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Metabolic and Systemic Heart Diseases
Metabolic and systemic heart diseases represent a complex intersection of multiple physiological systems, where conditions such as diabetes, obesity, and hypertension can significantly impact cardiovascular health. These systemic diseases often lead to changes in heart function, contributing to conditions like heart failure, coronary artery disease, and arrhythmias. Understanding the links between metabolic imbalances and cardiovascular outcomes is crucial for developing effective treatment strategies. Metabolic and systemic heart diseases require a multidisciplinary approach that combines pharmacological interventions, lifestyle modifications, and targeted therapies to address the root causes. By focusing on managing underlying metabolic conditions, healthcare providers can significantly reduce the risk of heart-related complications and improve long-term cardiovascular health.
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Federico Benetti
Benetti Foundation, Argentina
Uwe Peter Tigor
Auxilius Pharma, United States
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Praveen Veerabhadrappa
Penn State University, United States
Faizan Butt
Rutgers Jersey City Medical Center, United StatesSubmit your abstract Today
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Beyond PCSK9: The next wave of lipid-lowering and thrombosis prevention - from bench to breakthrough
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Current approaches to anti-angina drug treatment in Chronic-stable Angina Pectoris (CSAP) in US primary care and cardiology – A cross-sectional, blinded standard-of-care survey
Uwe Peter Tigor, Auxilius Pharma, United States